Endophthalmitis: Changes in Presentation, Management and the Role of Early Vitrectomy
Abstract Endophthalmitis is a sight-threatening condition, and its timely and appropriate management is essential in preventing permanent vision loss. Recent changes in clinical practice in endophthalmitis and advances in modern vitreoretinal surgery may limit the applicability of established randomised clinical trial evidence to current management. This review discusses the epidemiology, pathophysiology, changing patient presentation, diagnosis and advances in the management of endophthalmitis, presenting the existing literature on this topic and results from Sydney Eye Hospital..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Ophthalmology and therapy - 10(2021), 4 vom: 25. Okt., Seite 877-890 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Shao, Emily H. [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Endophthalmitis |
---|
Anmerkungen: |
© The Author(s) 2021 |
---|
doi: |
10.1007/s40123-021-00406-6 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR045560404 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR045560404 | ||
003 | DE-627 | ||
005 | 20230519224222.0 | ||
007 | cr uuu---uuuuu | ||
008 | 211113s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s40123-021-00406-6 |2 doi | |
035 | |a (DE-627)SPR045560404 | ||
035 | |a (SPR)s40123-021-00406-6-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q ASE |
100 | 1 | |a Shao, Emily H. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Endophthalmitis: Changes in Presentation, Management and the Role of Early Vitrectomy |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s) 2021 | ||
520 | |a Abstract Endophthalmitis is a sight-threatening condition, and its timely and appropriate management is essential in preventing permanent vision loss. Recent changes in clinical practice in endophthalmitis and advances in modern vitreoretinal surgery may limit the applicability of established randomised clinical trial evidence to current management. This review discusses the epidemiology, pathophysiology, changing patient presentation, diagnosis and advances in the management of endophthalmitis, presenting the existing literature on this topic and results from Sydney Eye Hospital. | ||
650 | 4 | |a Endophthalmitis |7 (dpeaa)DE-He213 | |
650 | 4 | |a Endophthalmitis vitrectomy study |7 (dpeaa)DE-He213 | |
650 | 4 | |a Pars plana vitrectomy |7 (dpeaa)DE-He213 | |
700 | 1 | |a Yates, William B. |e verfasserin |4 aut | |
700 | 1 | |a Ho, I.-Van |e verfasserin |4 aut | |
700 | 1 | |a Chang, Andrew A. |e verfasserin |4 aut | |
700 | 1 | |a Simunovic, Matthew P. |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Ophthalmology and therapy |d Berlin : SpringerOpen, 2012 |g 10(2021), 4 vom: 25. Okt., Seite 877-890 |w (DE-627)SPR032898037 |w (DE-600)2682230-1 |x 2193-6528 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2021 |g number:4 |g day:25 |g month:10 |g pages:877-890 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s40123-021-00406-6 |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 10 |j 2021 |e 4 |b 25 |c 10 |h 877-890 |